Maimonides Medical Center
Clinical trials sponsored by Maimonides Medical Center, explained in plain language.
-
New ankle device lets patients walk sooner after injury
Disease control Recruiting nowThis study tests a new device called Fibulink to repair a torn ankle ligament (syndesmosis) after certain fractures or sprains. About 56 adults will receive the device and start full weight-bearing in a walking boot at 4 weeks, which is earlier than usual. The goal is to see if t…
Phase: NA • Sponsor: Maimonides Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Which biopsy tool wins? study tests two devices for uterine cancer detection
Diagnosis Recruiting nowThis study compares two standard tools used to take a small tissue sample from the lining of the uterus (endometrial biopsy). The goal is to see which device works better at getting a good sample for diagnosing conditions like endometrial cancer. About 124 women aged 18 to 95 who…
Phase: PHASE4 • Sponsor: Maimonides Medical Center • Aim: Diagnosis
Last updated Jun 12, 2026 12:05 UTC
-
Testosterone cream may stop repeat UTIs in older women
Prevention Recruiting nowThis study tests whether a vaginal testosterone cream can prevent repeat urinary tract infections (UTIs) in postmenopausal women aged 60-90 who have had at least three UTIs. Participants will apply the cream or a placebo for 9 months and be monitored for infections. The goal is t…
Phase: PHASE4 • Sponsor: Maimonides Medical Center • Aim: Prevention
Last updated Jun 08, 2026 13:12 UTC
-
Can a light box beat daytime drowsiness in Prader-Willi syndrome?
Symptom relief Recruiting nowThis study tests whether bright light therapy can help reduce excessive daytime sleepiness in people with Prader-Willi syndrome. About 50 participants will receive either bright light or a placebo light to see if it improves alertness, mood, and behavior. The goal is to find a si…
Phase: NA • Sponsor: Maimonides Medical Center • Aim: Symptom relief
Last updated Jun 11, 2026 12:09 UTC
-
One pill to ease breast pain after pregnancy loss: new trial tests cabergoline
Symptom relief Recruiting nowThis study tests whether a single dose of cabergoline can prevent breast symptoms like pain, swelling, and milk leakage after abortion or pregnancy loss between 12 and 18 weeks. About 348 participants will receive either cabergoline or a placebo right after the procedure and repo…
Phase: PHASE2 • Sponsor: Maimonides Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:28 UTC